| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $4.44B | +0.5% |
| Cost of Revenue | $2.00B | +3.7% |
| R&D Expense | $344.0M | +5.2% |
| SG&A Expense | $1.31B | +2.3% |
| Pre-tax Income | $488.0M | +140.8% |
| Income Tax | $150.0M | +316.7% |
| Net Income | $338.0M | +127.5% |
| EPS (Basic) | $0.68 | +127.2% |
| EPS (Diluted) | $0.68 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $468.0M | +33.0% |
| Accounts Receivable | $805.0M | -4.4% |
| Inventory | $1.57B | -9.3% |
| Current Assets | $3.21B | -5.6% |
| Total Assets | $12.61B | -12.2% |
| Current Liabilities | $1.31B | +6.0% |
| Long-term Debt | $4.32B | -25.2% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $541.0M | +99.6% |
| Capital Expenditures | $147.0M | +5.0% |
| Investing Cash Flow | $1.16B | +785.2% |
| Financing Cash Flow | -$1.49B | -1697.6% |
| Free Cash Flow | $394.0M | +200.8% |
| +127.2% |
| Total Liabilities |
| $6.52B |
| -19.9% |
| Stockholders' Equity | $6.10B | -2.0% |